India Coronavirus Dispatch: Odisha facing a shortage of vaccine doses
The union
government's expert panel on new drugs and vaccines could meet later this week
to consider granting emergency approval to Sputnik V, Russia's Covid-19 vaccine, a report in The Print
said citing sources. Hyderabad-based drugmaker Dr. Reddy's Laboratories, which
conducted the clinical trials for the vaccine, has submitted the immunogenicity
data to the subject expert committee (SEC) of the Central Drugs Standards
Control Organization (CDSCO), India's national regulatory body for
pharmaceuticals and medical devices.
Odisha
might have to have to pause its coronavirus vaccination drive for a few days
because of a shortage in doses, according to a report by Reuters. The state's
additional chief secretary for health P.K. Mohapatra wrote to the central
health ministry to say Odisha only had enough doses to run its vaccination
drive until March 30. It is expecting another batch of Covishield only on April
2. “We will have no vaccines for 4 days,” Mohapatra said. “Hence, adequate
doses of Covishield vaccine may be supplied in time so as to continue
uninterrupted vaccination drive in our state. Your urgent attention is drawn to
the above issue.” Read More
Comments
Post a Comment